Multi-Omic Breakthroughs in Clinical Trials: Immune Monitoring for Precision Disease Detection
IMMUNOLOGY2025™ PRESENTATION
Watch the IMMUNOLOGY2025 presentation by Helen McGuire, PhD
What You'll Discover:
Dr. Helen McGuire reveals a specific proteomic immune signature that effectively predicts non-responsiveness to checkpoint therapies. Explore her methodology for integrating multi-omic datasets within a scalable framework designed for multi-center clinical trials. Learn how this approach enhances therapeutic decision-making through improved patient stratification.
In this must-watch session, Dr. McGuire reveals a novel proteomic immune signature that accurately forecasts non-responsiveness to checkpoint therapies—a discovery with immediate implications for trial design, patient stratification, and personalized treatment decisions.
Watch now to learn how these integrated approaches are reshaping therapeutic decision-making and improving clinical trial efficiency across the industry.
Defining standards
Our industry-leading proteomic and multi-omic solutions that scale
Every marker, all at once
Our industry-leading proteomic and multi-omic solutions that scale
High-resolution spatial proteomics
Highest dynamic range and througput
Ultrahigh-plex precision proteomics
Enable 11,000 protein measurements with unparalleled reproducibility
